Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -546,376 | -309,851 | -306,735 | -314,248 | -181,223 |
| Depreciation Amortization | 397,047 | 224,807 | 13,694 | 17,074 | 15,596 |
| Income taxes - deferred | -546 | -205 | -11,424 | N/A | -93,649 |
| Accounts receivable | -7,924 | 9,091 | -17,829 | 5,455 | -7,166 |
| Accounts payable and accrued liabilities | 2,482 | 1,405 | 206 | 1,025 | 6,363 |
| Other Working Capital | 4,442 | -40,578 | -58,957 | -53,972 | 20,327 |
| Other Operating Activity | 39,666 | -90,727 | 121,872 | 81,455 | 128,572 |
| Operating Cash Flow | $-111,209 | $-206,058 | $-259,173 | $-263,211 | $-111,180 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 123,162 | 130,192 | 13,549 | 133,012 | -352,807 |
| PPE Investments | -2,714 | -6,188 | -8,843 | -16,750 | -5,931 |
| Net Acquisitions | N/A | N/A | -102 | N/A | -319,793 |
| Purchase Sale Intangibles | -5,000 | 0 | 0 | -179 | N/A |
| Other Investing Activity | -5,000 | 0 | 0 | -179 | 0 |
| Investing Cash Flow | $115,448 | $124,004 | $4,604 | $116,083 | $-678,531 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 895,536 |
| Debt Repayment | 0 | -490 | -1,842 | -1,608 | -361 |
| Common Stock Issued | 3,428 | 7,703 | 204,519 | 11,230 | 326,651 |
| Other Financing Activity | 0 | -50,200 | -93,786 | 0 | -52,245 |
| Financing Cash Flow | $3,428 | $-42,987 | $108,891 | $9,622 | $1,169,581 |
| Beginning Cash Position | 57,592 | 182,633 | 328,311 | 465,817 | 85,947 |
| End Cash Position | 65,259 | 57,592 | 182,633 | 328,311 | 465,817 |
| Net Cash Flow | $7,667 | $-125,041 | $-145,678 | $-137,506 | $379,870 |
| Free Cash Flow | |||||
| Operating Cash Flow | -111,209 | -206,058 | -259,173 | -263,211 | -111,180 |
| Capital Expenditure | -2,714 | -6,188 | -8,843 | -16,750 | -5,931 |
| Free Cash Flow | -113,923 | -212,246 | -268,016 | -279,961 | -117,111 |